The super-pricey rare disease med Soliris fell short in a key myasthenia gravis trial, putting Alexion's ambitions for the new use in doubt. But top…

CHICAGO--The ASCO annual meeting is the biopharma version of Cannes or Sundance: Non-stop premieres, news conferences, sideline interviews and more. Track this…

Payers and healthcare systems seeking reprieve from growing cancer costs had better buckle in. According to a new report, a record number of debut meds will…

ASCO stepped up the drug-cost debate last year when it proposed a tool to help physicians and patients compare meds. Now, the group has tweaked that tool, and…

A new JAMA study offers more evidence that doctors who collect more pharma payments prescribe more branded meds. Now, it's statin scripts at center: The…

Should pharma marketers be more jazzed about the electronic health record industry? It's tough to tap, yes, but drugmakers need to start experimenting,…

What a difference a year has made in the life of pharma TV ads. A second annual patient view study from Treato just out found that the number of consumers who…

HealthPrize has talked up gamification as a way to get patients to stick to their meds. Now, the company has new data showing participants in its digital…

Data and Analytics